There have been some great years and some down years for approvals of novel molecular entities (NMEs) and biologic license applications (BLAs) from 2007-2016. Significant obstacles still need to be overcome in the worldwide clinical research trials industry, as seen by the gap between investment/activity and production. Three of the most pressing problems in the […]
- Mon – Fri: 09:00AM – 06:00PM
- 1236 Poydras St, Ste - 301A, New Orleans, LA 70113
- (+1) 504-420-7800